GRCE
Grace Therapeutics, Inc.
Company overview
- Market capitalization
- $44.60M
- Employees
- 5
- Latest publication
- 2026-09-29
About Grace Therapeutics, Inc.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Financial statements
Income Quarterly
| Metric | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 8,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,000USD | 4,116USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Gross Profit | -2,000USD | -4,116USD | -2,000USD | -2,000USD | -2,000USD | -2,000USD | -2,000USD | -1,000USD |
| Research Development | 420,000USD | 633,924USD | 792,206USD | 955,000USD | 2,326,995USD | 3,155,169USD | 2,976,000USD | 3,703,542USD |
| Selling General Administrative | 308,589USD | 2,723,678USD | 2,733,670USD | 2,133,000USD | 2,203,098USD | 2,170,077USD | 1,853,000USD | 3,082,638USD |
| Other Operating Expenses | 3,008,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 3,008,000USD | 3,360,346USD | 3,527,272USD | 3,090,000USD | 4,532,942USD | 5,326,685USD | 4,831,000USD | 6,787,547USD |
| Operating Income | -3,010,000USD | -3,360,346USD | -3,527,272USD | -3,090,000USD | -4,532,942USD | -5,326,685USD | -4,831,000USD | -6,787,547USD |
| Interest Income | 138,000USD | 170,000USD | 172,000USD | 205,000USD | 167,000USD | 138,000USD | 172,000USD | 235,000USD |
| Net Interest Income | 138,000USD | 170,000USD | 172,000USD | 205,000USD | 167,000USD | 138,000USD | 172,000USD | 235,000USD |
| Income Before Tax | -2,877,000USD | -3,176,480USD | -1,308,256USD | -3,362,000USD | -544,010USD | -6,845,308USD | -4,284,000USD | -4,569,251USD |
| Income Tax Expense | -1,700,000USD | — | — | — | -1,449,743USD | -870,044USD | -852,000USD | -990,164USD |
| Tax Provision | -1,700,000USD | 0USD | 0USD | 0USD | -1,018,000USD | -605,000USD | -852,000USD | -724,000USD |
| Net Income | -1,178,000USD | -3,176,480USD | -1,308,256USD | -3,362,000USD | 905,733USD | -5,975,263USD | -3,432,000USD | -3,579,087USD |
| Net Income From Continuing Ops | -1,178,000USD | -2,315,000USD | -938,000USD | -3,362,000USD | 636,000USD | -4,155,000USD | -3,432,000USD | -2,617,000USD |
| Ebit | -3,010,000USD | -3,360,345USD | -3,527,271USD | -3,090,000USD | -4,532,941USD | -5,326,685USD | -4,831,000USD | -6,787,547USD |
| Ebitda | -3,008,000USD | -3,356,229USD | -3,525,877USD | -3,088,000USD | -4,530,093USD | -5,323,809USD | -4,829,000USD | -6,786,180USD |
| Depreciation And Amortization | 2,000USD | 4,116USD | 1,394USD | 2,000USD | 2,848USD | 2,876USD | 2,000USD | 1,367USD |
| Reconciled Depreciation | 2,000USD | 3,000USD | 0USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 1,000USD |
| Total Other Income Expense Net | 132,000USD | 183,865USD | 2,219,015USD | -272,000USD | 3,988,932USD | -1,518,623USD | 547,000USD | 2,218,295USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 309,318USD | — | — |
| Cost Of Revenue | 6,999USD | 7,000USD | 11,000USD | 124,000USD | 0USD | 119,938USD | — | 3,122,619USD |
| Gross Profit | -6,999USD | -7,000USD | -11,000USD | -124,000USD | 0USD | 189,378USD | — | -3,122,619USD |
| Research Development | 2,405,000USD | 13,544,710USD | 6,354,877USD | 13,487,445USD | 6,945,822USD | 6,585,643USD | 31,919,155USD | 29,373,000USD |
| Selling General Administrative | 8,665,000USD | 10,198,051USD | 9,015,974USD | 10,923,045USD | 12,076,159USD | 8,700,371USD | 11,587,528USD | 3,798,000USD |
| Total Operating Expenses | 11,077,000USD | 23,752,730USD | 17,440,292USD | 70,541,289USD | 19,478,039USD | 26,101,116USD | 48,831,870USD | 34,406,000USD |
| Operating Income | -11,077,000USD | -23,752,730USD | -17,440,292USD | -70,541,289USD | -19,478,039USD | -25,911,738USD | -48,831,870USD | -34,406,000USD |
| Interest Income | 685,000USD | 711,000USD | 911,000USD | 246,000USD | 77,000USD | 107,000USD | — | — |
| Net Interest Income | 685,000USD | 711,000USD | 911,000USD | 246,000USD | 77,000USD | -157,000USD | — | — |
| Income Before Tax | -9,493,000USD | -18,181,612USD | -19,927,691USD | -70,292,423USD | -13,078,237USD | -31,054,946USD | -50,979,929USD | -39,366,000USD |
| Income Tax Expense | -1,700,000USD | -4,555,727USD | -2,486,042USD | -12,905,857USD | -809,658USD | — | — | — |
| Tax Provision | -1,700,000USD | -3,199,000USD | -1,832,000USD | -9,542,000USD | -648,000USD | 0USD | — | — |
| Net Income | -7,793,000USD | -13,625,884USD | -17,441,649USD | -57,386,566USD | -12,268,578USD | -31,054,946USD | -50,979,929USD | -39,366,000USD |
| Net Income From Continuing Ops | -7,793,000USD | -9,568,000USD | -12,853,000USD | -42,429,000USD | -9,819,000USD | -19,678,000USD | — | — |
| Ebit | -11,077,000USD | -23,752,729USD | -15,425,132USD | -24,679,644USD | -15,589,000USD | -16,911,514USD | -50,486,374USD | -39,088,000USD |
| Ebitda | -11,070,000USD | -23,742,761USD | -15,370,852USD | -24,511,931USD | -19,166,920USD | -15,453,300USD | -45,850,564USD | -36,755,000USD |
| Depreciation And Amortization | 7,000USD | 9,968USD | 54,280USD | 167,713USD | — | 1,458,214USD | 4,635,810USD | 2,333,000USD |
| Reconciled Depreciation | 7,000USD | 7,000USD | 11,000USD | 124,000USD | 0USD | 924,000USD | — | — |
| Total Other Income Expense Net | 1,584,000USD | 5,571,118USD | -2,487,399USD | 248,865USD | 6,399,802USD | -5,143,208USD | -2,148,058USD | -4,960,000USD |
| Selling And Marketing Expenses | — | — | 194,000USD | 183,944USD | 144,938USD | 1,802,252USD | 5,325,187USD | 494,000USD |
| Unclassified Operating Expenses | — | — | 1,875,441USD | 45,946,855USD | — | 9,012,850USD | — | — |
| Interest Expense | — | — | — | — | — | 331,649USD | 414,177USD | 1,050,688USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 50,073,000USD | 66,654,000USD | 68,488,000USD | 66,576,000USD | 71,993,000USD | 61,224,000USD | 65,349,000USD | 69,718,000USD |
| Cash And Equivalents | 13,756,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 14,333,000USD | 17,380,000USD | 19,211,000USD | 17,298,000USD | 22,712,000USD | 11,939,000USD | 16,062,000USD | 20,429,000USD |
| Total Liabilities | 1,862,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,250,000USD | 2,146,000USD | 1,284,000USD | 1,245,000USD | 1,930,000USD | 1,971,000USD | 2,674,000USD | 2,600,000USD |
| Total Stockholder Equity | 48,211,000USD | 63,896,000USD | 64,892,000USD | 62,818,000USD | 66,610,000USD | 52,139,000USD | 56,134,000USD | 59,364,000USD |
| Total Equity Including Noncontrolling Interest | 48,211,000USD | — | — | — | — | — | — | — |
| Goodwill | 8,138,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 27,595,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD |
| Accounts Payable | 408,000USD | 702,000USD | 156,422USD | 459,000USD | 601,000USD | 665,000USD | 1,675,000USD | 1,549,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 261,038,000USD | 261,038,000USD |
| Retained Earnings | -244,270,000USD | -228,480,000USD | -227,302,000USD | -224,987,000USD | -220,687,000USD | -221,323,000USD | -217,168,000USD | -213,736,000USD |
| Accumulated Other Comprehensive Income | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD |
| Other Current Assets | — | 383,000USD | 519,000USD | 416,000USD | 453,000USD | 583,000USD | 477,000USD | 622,000USD |
| Total Liab | — | 2,758,000USD | 3,596,000USD | 3,758,000USD | 5,383,000USD | 9,085,000USD | 9,215,000USD | 10,354,000USD |
| Other Current Liab | — | 1,444,000USD | 1,127,578USD | 786,000USD | 1,329,000USD | 1,306,000USD | 999,000USD | 1,051,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 261,038,000USD | 261,038,000USD |
| Good Will | — | 8,138,000USD | 8,138,000USD | 8,138,000USD | 8,138,000USD | 8,138,000USD | 8,138,000USD | 8,138,000USD |
| Cash | — | 16,977,000USD | 18,672,000USD | 16,862,000USD | 22,133,000USD | 11,055,000USD | 15,155,000USD | 19,394,000USD |
| Cash And Short Term Investments | — | 16,977,000USD | 18,672,000USD | 16,862,000USD | 22,133,000USD | 11,055,000USD | 15,170,000USD | 19,409,000USD |
| Net Debt | — | -16,977,000USD | -18,672,000USD | -16,862,000USD | -22,133,000USD | -11,055,000USD | -15,155,000USD | -19,394,000USD |
| Net Receivables | — | 20,000USD | 20,000USD | 20,000USD | 126,000USD | 301,000USD | 415,000USD | 398,000USD |
| Property Plant Equipment Net | — | 8,000USD | 11,000USD | 12,000USD | 15,000USD | 18,999USD | 21,000USD | 23,000USD |
| Property Plant Equipment Gross | — | 22,000USD | 11,000USD | 12,000USD | 26,000USD | 19,000USD | 21,000USD | 23,000USD |
| Common Stock Shares Outstanding | — | 16,510,632shares | 16,933,620shares | 15,924,522shares | 14,005,896shares | 11,506,234shares | 11,506,234shares | 10,928,543shares |
| Non Current Assets Total | — | 49,274,000USD | 49,277,000USD | 49,278,000USD | 49,281,000USD | 49,285,000USD | 49,287,000USD | 49,289,000USD |
| Non Current Liabilities Total | — | 612,000USD | 2,312,000USD | 2,513,000USD | 3,453,000USD | 7,114,000USD | 6,541,000USD | 7,754,000USD |
| Net Working Capital | — | 15,234,000USD | 17,927,000USD | 16,053,000USD | 20,782,000USD | 9,968,000USD | 13,388,000USD | 17,829,000USD |
| Unclassified Equity | — | 298,412,000USD | 298,230,000USD | 293,841,000USD | 293,333,000USD | 279,498,000USD | -242,736,000USD | -242,938,000USD |
| Non Currrent Assets Other | — | — | 11,000USD | 12,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | 2,312,000USD | 2,513,000USD | 3,453,000USD | 7,114,000USD | 6,541,000USD | 7,754,000USD |
| Short Term Investments | — | — | — | — | — | — | 15,000USD | 15,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 66,654,000USD | 71,993,000USD | 73,300,000USD | 79,123,000USD | 128,620,000USD | 78,462,654USD | 32,304,429USD | 36,896,000USD |
| Intangible Assets | 41,128,000USD | 41,128,000USD | 41,128,000USD | 41,128,000USD | 69,810,000USD | — | 5,999,212USD | 6,386,000USD |
| Other Current Assets | 383,000USD | 453,000USD | 283,000USD | 598,000USD | 1,322,000USD | 1,395,689USD | 1,656,708USD | 615,576USD |
| Total Liab | 2,758,000USD | 5,383,000USD | 11,557,000USD | 11,168,000USD | 20,350,000USD | 8,539,964USD | 13,936,435USD | 25,851,000USD |
| Total Stockholder Equity | 63,896,000USD | 66,610,000USD | 61,743,000USD | 67,955,000USD | 108,270,000USD | 69,922,689USD | 18,367,993USD | 11,045,000USD |
| Other Current Liab | 1,444,000USD | 1,329,000USD | 677,000USD | 2,094,000USD | 1,374,000USD | 1,731,107USD | 7,955,933USD | 9,260,000USD |
| Common Stock | 1,000USD | 1,000USD | 261,038,000USD | 258,293,999USD | 257,990,000USD | 247,724,305USD | 194,259,130USD | 110,857,000USD |
| Capital Stock | 1,000USD | 1,000USD | 261,038,000USD | 258,294,000USD | 257,990,000USD | 197,194,000USD | — | — |
| Retained Earnings | -228,480,000USD | -220,687,000USD | -211,119,000USD | -198,266,000USD | -155,837,000USD | -183,434,625USD | -178,591,065USD | -100,827,000USD |
| Good Will | 8,138,000USD | 8,138,000USD | 8,138,000USD | 8,138,000USD | 12,964,000USD | 0USD | — | — |
| Cash | 16,977,000USD | 22,133,000USD | 23,005,000USD | 27,875,000USD | 30,339,000USD | 63,995,717USD | 20,129,308USD | 16,871,000USD |
| Cash And Short Term Investments | 16,977,000USD | 22,133,000USD | 23,005,000USD | 27,890,000USD | 43,661,000USD | 76,293,116USD | 20,129,308USD | 25,759,000USD |
| Total Current Assets | 17,380,000USD | 22,712,000USD | 24,010,000USD | 29,290,000USD | 45,531,000USD | 78,354,617USD | 22,557,829USD | 27,966,000USD |
| Total Current Liabilities | 2,146,000USD | 1,930,000USD | 1,684,000USD | 3,411,000USD | 3,260,000USD | 1,983,613USD | 10,453,387USD | 13,668,000USD |
| Net Debt | -16,977,000USD | -22,133,000USD | -23,005,000USD | -27,390,000USD | -30,044,000USD | -63,887,679USD | -19,921,512USD | -15,510,000USD |
| Net Receivables | 20,000USD | 126,000USD | 722,000USD | 802,000USD | 548,000USD | 665,810USD | 771,811USD | 1,591,424USD |
| Accounts Payable | 702,000USD | 601,000USD | 1,007,000USD | 1,242,000USD | 3,156,000USD | 144,468USD | 2,421,453USD | 3,047,000USD |
| Property Plant Equipment Net | 8,000USD | 15,000USD | 24,000USD | 567,000USD | 315,000USD | 108,037USD | 2,907,723USD | 2,107,000USD |
| Property Plant Equipment Gross | 22,000USD | 26,000USD | 722,000USD | 1,176,000USD | 1,011,000USD | 86,000USD | — | — |
| Accumulated Other Comprehensive Income | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,038,000USD | -6,037,000USD | -7,955,810USD | -11,148,866USD | — |
| Common Stock Shares Outstanding | 16,510,632shares | 12,087,270shares | 9,529,123shares | 7,435,472shares | 6,140,293shares | 2,471,372shares | 1,762,120shares | 1,131,047shares |
| Non Current Assets Total | 49,274,000USD | 49,281,000USD | 49,290,000USD | 49,833,000USD | 83,089,000USD | 108,035USD | 9,746,599USD | 8,930,000USD |
| Non Current Liabilities Total | 612,000USD | 3,453,000USD | 9,873,000USD | 7,757,000USD | 17,090,000USD | 6,556,351USD | 3,483,048USD | 12,183,000USD |
| Net Working Capital | 15,234,000USD | 20,782,000USD | 22,326,000USD | 25,879,000USD | 42,021,000USD | 60,793,000USD | — | — |
| Unclassified Equity | 298,412,000USD | 293,333,000USD | -243,176,000USD | -244,328,999USD | -245,836,000USD | -183,605,181USD | 13,848,794USD | 1,015,000USD |
| Non Currrent Assets Other | — | 15,000USD | — | — | — | — | 839,663USD | 417,000USD |
| Unclassified Non Current Liabilities | — | 3,453,000USD | 9,873,000USD | 7,757,000USD | 17,090,000USD | 6,556,351USD | 3,483,048USD | 12,183,000USD |
| Short Term Investments | — | — | 0USD | 15,000USD | 13,322,000USD | 12,297,398USD | 9,789,000USD | 8,888,000USD |
| Short Term Debt | — | — | — | 75,000USD | 104,000USD | 108,037USD | 76,000USD | 1,361,000USD |
| Short Long Term Debt Total | — | — | — | 485,000USD | 295,000USD | 108,037USD | 147,000USD | 1,361,000USD |
| Unclassified Current Liabilities | — | — | — | — | -1,374,000USD | — | — | — |
| Unclassified Current Assets | — | — | — | — | — | — | -9,788,998USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q2 20252024-09-30 · USD | Q1 20252024-06-30 · USD | Q3 20242023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 2,000USD | 2,000USD | 3,000USD | 0USD | 2,000USD | 2,000USD | 1,000USD | 1,000USD |
| Stock Based Compensation | 105,000USD | -24,000USD | 314,000USD | 206,000USD | 130,000USD | 202,000USD | 238,000USD | 326,000USD |
| Operating Cash Flow | -3,221,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 0USD | — | — | — | — | — | — | — |
| Change In Cash | -3,221,000USD | -1,695,000USD | 1,810,000USD | -3,143,000USD | 11,078,000USD | -4,239,000USD | -3,611,000USD | -8,446,000USD |
| End Cash Flow | 13,756,000USD | — | — | — | — | — | — | — |
| Net Income | — | -1,177,000USD | -2,315,000USD | -938,000USD | 636,000USD | -3,432,000USD | -2,617,000USD | -2,391,000USD |
| Other Non Cash Items | — | 189,708USD | -131,575USD | -1,233,138USD | -2,638,000USD | -361,000USD | -1,395,000USD | -126,000USD |
| Change To Account Receivables | — | 1,481USD | -1,273USD | 250USD | 175,000USD | -19,000USD | 326,000USD | -122,000USD |
| Change In Working Capital | — | 1,002,653USD | -88,785USD | -983,501USD | -66,000USD | 202,000USD | 901,000USD | 506,000USD |
| Total Cash From Operating Activities | — | -1,706,639USD | -2,218,361USD | -3,154,639USD | -2,954,000USD | -4,239,000USD | -3,596,000USD | -1,892,000USD |
| Capital Expenditures | — | 0USD | 0USD | 0USD | 0USD | -4USD | 0USD | 0USD |
| Free Cash Flow | — | -1,706,639USD | -2,218,360USD | -3,154,640USD | -2,954,000USD | -4,239,000USD | -3,596,000USD | -1,892,000USD |
| Investments | — | 0USD | 0USD | 0USD | 0USD | 0USD | -15,000USD | -6,554,000USD |
| Total Cash From Financing Activities | — | -769USD | 4,040,769USD | -769USD | 14,032,000USD | 0USD | 0USD | -65,333USD |
| Issuance Of Capital Stock | — | -4,040,000USD | — | — | 14,999,000USD | — | — | 0USD |
| Begin Period Cash Flow | — | 18,672,000USD | 16,862,000USD | 20,005,000USD | 11,055,000USD | 19,394,000USD | 23,005,000USD | 26,991,000USD |
| End Period Cash Flow | — | 16,977,000USD | 18,672,000USD | 16,862,000USD | 22,133,000USD | 15,155,000USD | 19,394,000USD | 18,545,000USD |
| Other Cashflows From Financing Activities | — | -52,647USD | -1,471,090USD | — | -967,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | -1,700,000USD | — | — | -1,018,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | 4,091,878USD | 5,511,859USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | -15,000USD | — | — | — |
| Total Cashflows From Investing Activities | — | — | — | — | — | -23USD | -15,000USD | -6,554,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-03-31 · USD | FY 20192019-03-31 · USD | FY 20182018-03-31 · USD | FY 20172017-03-31 · USD | FY 20162016-03-31 · USD | FY 20152015-03-31 · USD | FY 20142014-03-31 · USD | FY 20132013-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,793,000USD | -39,366,000USD | -16,651,566USD | -7,909,317USD | -4,661,614USD | -1,322,761USD | -10,435,936USD | -6,732,463USD |
| Depreciation | 7,000USD | 2,333,000USD | 2,069,056USD | 1,925,465USD | 1,767,384USD | 1,866,253USD | 1,594,230USD | 649,601USD |
| Stock Based Compensation | 798,000USD | 777,000USD | 719,368USD | — | 228,025USD | 1,241,238USD | 3,093,235USD | 1,872,739USD |
| Other Non Cash Items | -900,000USD | 5,281,000USD | 1,394,601USD | 278,382USD | -2,154,805USD | -8,581,566USD | 646,199USD | -72,969USD |
| Change To Account Receivables | 106,000USD | -620,000USD | -428,214USD | 147,036USD | 336,504USD | 235,779USD | -282,469USD | 241,055USD |
| Change In Working Capital | 719,000USD | 6,188,000USD | 2,774,486USD | 603,382USD | -30,255USD | 1,043,822USD | -1,013,286USD | 1,793,333USD |
| Total Cash From Operating Activities | -8,869,000USD | -24,787,000USD | -9,694,055USD | -5,200,366USD | -4,851,266USD | -5,753,015USD | -6,115,558USD | -2,489,760USD |
| Capital Expenditures | 0USD | -534,000USD | -352,328USD | -1,925,184USD | -271,564USD | -68,735USD | -133,562USD | -100,676USD |
| Free Cash Flow | -8,869,000USD | -25,321,000USD | -10,046,383USD | -7,125,550USD | -5,122,831USD | -5,821,750USD | -6,249,121USD | -2,590,437USD |
| Investments | 0USD | — | — | — | — | — | — | — |
| Total Cash From Financing Activities | 3,713,000USD | 45,690,000USD | 8,832,206USD | 5,243,029USD | -2,213USD | 36,765USD | 22,435,431USD | 221,530USD |
| Issuance Of Capital Stock | 0USD | — | — | — | — | — | — | — |
| Change In Cash | -5,156,000USD | 10,448,000USD | -1,199,464USD | -2,234,565USD | 1,266,317USD | 507,524USD | -468,317USD | -384,119USD |
| Begin Period Cash Flow | 22,133,000USD | 6,423,000USD | 7,566,922USD | 2,234,565USD | 967,449USD | 540,294USD | 1,075,412USD | 1,552,927USD |
| End Period Cash Flow | 16,977,000USD | 16,871,000USD | 6,367,458USD | 7,566,922USD | 2,233,767USD | 1,047,819USD | 607,094USD | 1,168,808USD |
| Unclassified Operating Cash Flow | -1,700,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 3,713,000USD | 44,892,000USD | 8,568,153USD | — | — | — | 21,588,629USD | — |
| Total Cashflows From Investing Activities | — | -9,442,000USD | -318,256USD | 5,133,323USD | 6,072,569USD | 6,095,894USD | -17,477,286USD | 1,854,661USD |
| Other Cashflows From Financing Activities | — | 798,000USD | 295,026USD | — | -2,213USD | 36,765USD | 846,802USD | 221,530USD |
| Unclassified Investing Cash Flow | — | -8,908,000USD | — | 7,058,507USD | 6,327,899USD | 6,172,621USD | -17,320,827USD | 1,953,601USD |
| Sale Purchase Of Stock | — | — | -30,973USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | 54,204USD | — | 16,234USD | -7,992USD | -22,897USD | 1,736USD |
| Change To Inventory | — | — | — | — | 64,939USD | 139,069USD | -35,326USD | 368,577USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.